Section Arrow
Quote
QNCX.NASDAQ
- Quince Therapeutics Inc.
Quotes are at least 15-min delayed:2026/09/04 09:34 EDT
Regular Hours
Last
 30.53
-0.02 (-0.07%)
Day High 
30.53 
Prev. Close
30.55 
1-M High
35.41 
Volume 
205 
Bid
30
Ask
33.37
Day Low
30.53 
Open
30.53 
1-M Low
24.8097 
Market Cap 
31.07M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 32.33 
20-SMA 32.41 
50-SMA 24.91 
52-W High 909.98 
52-W Low 15.1 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-210.84/-3.49
Enterprise Value
31.40M
Balance Sheet
Book Value Per Share
-34.73
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IMRNImmuron Limited1.925+0.815+73.42%-- 
CMNDClearmind Medicine Inc.1.4599-0.2401-14.12%-- 
CABACabaletta Bio3.5+0.02+0.57%-- 
MRNAModerna148.5-0.37-0.25%-- 
RAREUltragenyx Pharmaceutical15.7+0.85+5.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.